Stocks / TGTX / Total Debt

TG Therapeutics, Inc. Total Debt 2011–2025

TG Therapeutics, Inc. reported $245.65M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +721.7%.

Latest filed value
$245.65M
One-year change
+0.5%
Change since 2020
+721.7%
Latest period end
2025
TG Therapeutics, Inc. Total Debt history from 2011 to 2025FY 2011: 0FY 2012: 0FY 2013: 0FY 2014: 0FY 2015: 0FY 2016: 0FY 2017: 0FY 2018: 0FY 2019: 28970000FY 2020: 29895000FY 2021: 67763000FY 2022: 71135000FY 2023: 100403000FY 2024: 244429000FY 2025: 245645000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearTotal DebtChange (YoY)
FY 2025$245.65M+0.5%
FY 2024$244.43M+143.4%
FY 2023$100.40M+41.1%
FY 2022$71.14M+5.0%
FY 2021$67.76M+126.7%
FY 2020$29.89M+3.2%
FY 2019$28.97M
FY 2018$0
FY 2017$0
FY 2016$0
FY 2015$0
FY 2014$0
FY 2013$0
FY 2012$0
FY 2011$0

Source: TG Therapeutics, Inc. SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TGTX 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

TG Therapeutics, Inc. reported $245.65M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +721.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for TG Therapeutics, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

TG Therapeutics, Inc. — frequently asked questions

What is TG Therapeutics, Inc.'s total debt (short- plus long-term borrowings)?

TG Therapeutics, Inc. (TGTX) reported total debt (short- plus long-term borrowings) of $245.65M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from TG Therapeutics, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.

More TGTX financial history

Full TGTX fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →